{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:59Z","timestamp":1792512119430,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-025-00435-1","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:03:18Z","timestamp":1770688998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of cardiac amyloidosis on patients with multiple myeloma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Giuseppina","family":"Novo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Madaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Orilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Camilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Buccheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Ruggero","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"435_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajh.27177","volume":"99","author":"MA Gertz","year":"2024","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol. 2024;99:309\u201324.","journal-title":"Am J Hematol"},{"key":"435_CR2","unstructured":"Albagoush SA, Shumway C, Azevedo AM. Multiple Myeloma. 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534764\/."},{"key":"435_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00277-008-0554-0","volume":"88","author":"J Vela-Ojeda","year":"2009","unstructured":"Vela-Ojeda J, Garc\u00eda-Ruiz Esparza MA, Padilla-Gonz\u00e1lez Y, S\u00e1nchez-Cortes E, Garc\u00eda-Ch\u00e1vez J, Montiel-Cervantes L, Reyes-Maldonado E, Majluf-Cruz A, Mayani H. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor. Ann Hematol. 2009;88:59\u201366.","journal-title":"Ann Hematol"},{"key":"435_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","volume":"38","author":"NJ Bahlis","year":"2006","unstructured":"Bahlis NJ, Lazarus HM. Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transpl. 2006;38:7\u201315.","journal-title":"Bone Marrow Transpl"},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0889-8588(05)70122-2","volume":"13","author":"MA Gertz","year":"1999","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A. AMYLOIDOSIS. Hematol Oncol Clin North Am. 1999;13:1211\u201333.","journal-title":"Hematol Oncol Clin North Am"},{"key":"435_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8","volume":"82","author":"SV Rajkumar","year":"1998","unstructured":"Rajkumar SV, Gertz MA, Kyle RA. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer. 1998;82:1501\u20135.","journal-title":"Cancer"},{"key":"435_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/10428199709059685","volume":"27","author":"KR Desikan","year":"1997","unstructured":"Desikan KR, Dhodapkar MV, Hough A, Waldron T, Jagannath S, Siegel D, Barlogie B, Tricot G. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leuk Lymphoma. 1997;27:315\u20139.","journal-title":"Leuk Lymphoma"},{"key":"435_CR8","doi-asserted-by":"publisher","first-page":"e006588","DOI":"10.1161\/CIRCIMAGING.117.006588","volume":"11","author":"P Milani","year":"2018","unstructured":"Milani P, Dispenzieri A, Scott CG, Gertz MA, Perlini S, Mussinelli R, Lacy MQ, Buadi FK, Kumar S, Maurer MS, Merlini G, Hayman SR, Leung N, Dingli D, Klarich KW, Lust JA, Lin Y, Kapoor P, Go RS, Pellikka PA, Hwa YL, Zeldenrust SR, Kyle RA, Rajkumar SV, Grogan M. Independent prognostic value of stroke volume index in patients with Immunoglobulin light chain amyloidosis. Circ Cardiovasc Imaging. 2018;11:e006588.","journal-title":"Circ Cardiovasc Imaging"},{"key":"435_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) cardiac amyloidosis. J Am Coll Cardiol. 2016;68:1323\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"435_CR10","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","volume":"18","author":"A Martinez-Naharro","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med. 2018;18:s30\u20135.","journal-title":"Clin Med"},{"key":"435_CR11","unstructured":"Anon. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.training.cochrane.org\/handbook."},{"key":"435_CR12","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. https:\/\/www.bmj.com\/content\/372\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"435_CR13","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Morgan RL, Rooney AA, Taylor KW, Thayer KA, Silva RA, Lemeris C, Akl EA, Bateson TF, Berkman ND, Glenn BS, Hr\u00f3bjartsson A, LaKind JS, McAleenan A, Meerpohl JJ, Nachman RM, Obbagy JE, O\u2019Connor A, Radke EG, Savovi\u0107 J, Sch\u00fcnemann HJ, Shea B, Tilling K, Verbeek J, Viswanathan M, Sterne JAC. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186. https:\/\/www.rti.org\/publication\/tool-assess-risk-bias-non-randomized-follow-studies-exposure-effects-robins-e.","DOI":"10.1016\/j.envint.2024.108602"},{"key":"435_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2147\/CMAR.S287922","volume":"13","author":"J Xu","year":"2021","unstructured":"Xu J, Wang M, Shen Y, Yan M, Xie W, Wang B, Liu H, Cen X. Effects of amyloid light-chain amyloidosis on clinical characteristics and prognosis in multiple myeloma: A single-center retrospective study. Cancer Manag Res. 2021;13:1343\u201356.","journal-title":"Cancer Manag Res"},{"key":"435_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4065\/mcp.2009.0547","volume":"85","author":"S Madan","year":"2010","unstructured":"Madan S, Dispenzieri A, Lacy MQ, Buadi F, Hayman SR, Zeldenrust SR, Rajkumar SV, Gertz MA, Kumar SK. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. Mayo Clin Proc. 2010;85:232\u20138.","journal-title":"Mayo Clin Proc"},{"key":"435_CR16","doi-asserted-by":"publisher","first-page":"994384","DOI":"10.3389\/fcvm.2022.994384","volume":"9","author":"J Wang","year":"2022","unstructured":"Wang J, Yang S, Liao P, Zeng L, Ling W, Wan L, Weng J, Zhong L. Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma. Front Cardiovasc Med. 2022;9:994384.","journal-title":"Front Cardiovasc Med"},{"key":"435_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clml.2020.01.002","volume":"20","author":"Y Yu","year":"2020","unstructured":"Yu Y, Huang Z, Hu W, Li X, Shen M, Zhang J, Tang R, Chen S, Chen W. Clinical analysis of cardiac involvement in 53 patients with multiple myeloma coexistent with light chain amyloidosis. Clin Lymphoma Myeloma Leuk. 2020;20:519\u2013e5251.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"435_CR18","doi-asserted-by":"crossref","unstructured":"Lisi D, Di, Madaudo C, Damerino G, Damiani F, Stabile F, Puccia G, Scelfo D, Galassi AR, Novo G. Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA\/ICOS risk score and other parameters. Eur Heart J Supplements. 2025;27. https:\/\/academic.oup.com\/eurheartjsupp\/article\/27\/Supplement_6\/suaf083.089\/8220078.","DOI":"10.1093\/eurheartjsupp\/suaf083.089"},{"key":"435_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJM199106273242603","volume":"324","author":"A Solomon","year":"1991","unstructured":"Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med. 1991;324:1845\u201351.","journal-title":"N Engl J Med"},{"key":"435_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898\u2013909.","journal-title":"N Engl J Med"},{"key":"435_CR21","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.21902","volume":"54","author":"II van Gameren","year":"2006","unstructured":"van Gameren II, Hazenberg BPC, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015\u201321.","journal-title":"Arthritis Rheum"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/archinte.1988.00380030168027","volume":"148","author":"PA Pellikka","year":"1988","unstructured":"Pellikka PA. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med. 1988;148:662\u20136.","journal-title":"Arch Intern Med"},{"key":"435_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/17474086.2021.2003704","volume":"14","author":"M Camilli","year":"2021","unstructured":"Camilli M, Vecchia G, La, Lillo R, Iannaccone G, Lamendola P, Montone RA, Hohaus S, Aspromonte N, Massetti M, Lanza GA, Crea F, Graziani F, Lombardo A. Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances. Expert Rev Hematol. 2021;14:1115\u201328.","journal-title":"Expert Rev Hematol"},{"key":"435_CR24","first-page":"611","volume":"151","author":"P Cacoub","year":"2000","unstructured":"Cacoub P, Axler O, Zuttere D, De, Hausfater P, Amoura Z, Walter S, Wechsler B, Godeau P, Piette J. Amyloidosis and cardiac involvement. Ann Med Interne (Paris). 2000;151:611\u20137.","journal-title":"Ann Med Interne (Paris)"},{"key":"435_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","volume":"133","author":"B Lilleness","year":"2019","unstructured":"Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood. 2019;133:215\u201323.","journal-title":"Blood"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00435-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:09:07Z","timestamp":1771510147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-025-00435-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00435-1","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}